Myanmar

Dexa Medica began exporting its products to Myanmar in 1993, and held its inaugural scientific symposium there in 2001. Today, the company exports over twenty-five products to Myanmar, across product categories such as antibiotics, pain killers, cardiovascular drugs, and metabolic drugs. Dexa Medica’s flagship product, the corticosteroid Medixon, is also widely used in the country.